home / stock / lxg:cc / lxg:cc news

LXG:CC News and Press, Lexagene Holdings Inc.

Stock Information
Company Name: Lexagene Holdings Inc.
Stock Symbol: LXG:CC
Market: TSXVC
Menu
LXG:CC LXG:CC Quote LXG:CC Short LXG:CC News LXG:CC Articles LXG:CC Message Board
Get LXG:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
LXG:CC - TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC , Feb. 24, 2023 /CNW/ - TSX VENTURE COMPANIES CORNERSTONE CAPITAL RESOURCES INC. ("CGP") BULLETIN TYPE:  Plan of Arrangement, Delist BULLETIN DATE: ...
LXG:CC - LexaGene Files for Chapter 7 Bankruptcy

BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ceased operations, laid off its staff, and, together with its direct subsidiary LexaGene, Inc., and its indir...

LXG:CC - IIROC Trading Halt - LXG

IIROC Trading Halt - LXG Canada NewsWire VANCOUVER, BC , Feb. 21, 2023 /CNW/ - The following issues have been halted by IIROC: Company: Lexagene Holdings Inc. TSX-Venture Symbol: LXG All Issues: Yes Reason: Pending News Halt Time (ET):...

LXG:CC - LexaGene Holdings Announces Results of February 8, 2023 Annual General Meeting

BEVERLY, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab™ System for automated mul...
LXG:CC - LexaGene Provides Update on BioPharma Sector

BEVERLY, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab™ System for automate...

LXG:CC - LexaGene's MiQLab System Detects Mycoplasma at Minute Levels, Rousing Additional Interest from BioPharma Customers

BEVERLY, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab TM System for autom...

LXG:CC - BioPharma Engages LexaGene in Second Feasibility Study

BEVERLY, Mass. , Dec. 16, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, ge...
LXG:CC - LexaGene Successfully Completes Statement of Work for BioPharma Company

BEVERLY, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automate...

LXG:CC - LexaGene Closes Secured Convertible Note Transaction

BEVERLY, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab® System for automated...

LXG:CC - LexaGene Holdings Proposes to Amend Warrants Terms

BEVERLY, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab® System for automated...
Next 10